Sierra oncology inc

Major-Pharmaceuticals

SRRA

YTD

  • 151%
    May 23, 2022

Returns +
Q

2022 2021 2020 2019 2018 2017 2016 2015 2014
Q1.. 48.7% 7.5% 2831.3% 29.6% -44.5% - - - -
Q2 69.4% 13% 23.2% -65.7% 49.5% -23.5% - - -
Q3 - 12.6% -11.8% -27.8% -44.8% 32.5% - - -
Q4 - -1.5% 50.2% -16.9% -20% 134.6% - - -

Returns +
M

J F M A M J J A S O N D
2022 24.2% 14.5% 4.6% 68.7% 0.2% - - - - - - -
2021 -9.7% 0.2% 18.7% 5.9% -1.9% 8.8% -2.4% 7% 7.9% -8.8% 16.5% -5.3%

Returns +
A

    2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
    151%36%4685%-75%-65%0%0%0%0%0%0%